Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bortezomib, Lenalidomide and Dexamethasone (VRd) vs Carfilzomib, Lenalidomide and Dexamethasone (KRd) as Induction Therapy in Newly Diagnosed Multiple Myeloma.
Tan CR, Derkach A, Nemirovsky D, Ciardiello A, Diamond B, Hultcrantz M, Hassoun H, Mailankody S, Shah U, Maclachlan K, Patel D, Lahoud O, Landau H, Chung D, Shah G, Scordo M, Giralt S, Lesokhin A, Usmani S, Landgren O, Korde N. Tan CR, et al. Among authors: nemirovsky d. Res Sq [Preprint]. 2023 Feb 24:rs.3.rs-2583053. doi: 10.21203/rs.3.rs-2583053/v1. Res Sq. 2023. Update in: Blood Cancer J. 2023 Jul 25;13(1):112. doi: 10.1038/s41408-023-00882-y. PMID: 36865246 Free PMC article. Updated. Preprint.
Comparison of infectious complications with BCMA-directed therapies in multiple myeloma.
Nath K, Shekarkhand T, Nemirovsky D, Derkach A, Costa BA, Nishimura N, Farzana T, Rueda C, Chung DJ, Landau HJ, Lahoud OB, Scordo M, Shah GL, Hassoun H, Maclachlan K, Korde N, Shah UA, Tan CR, Hultcrantz M, Giralt SA, Usmani SZ, Shahid Z, Mailankody S, Lesokhin AM. Nath K, et al. Among authors: nemirovsky d. Blood Cancer J. 2024 May 31;14(1):88. doi: 10.1038/s41408-024-01043-5. Blood Cancer J. 2024. PMID: 38821925 Free PMC article.
Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma.
Hultcrantz M, Hassoun H, Korde N, MacLachlan K, Mailankody S, Patel D, Shah UA, Tan CR, Chung DJ, Lahoud OB, Landau HJ, Scordo M, Shah GL, Giralt SA, Pianko MJ, Burge M, Barnett K, Salcedo M, Caple J, Tran L, Blaslov J, Shekarkhand T, Hamid S, Nemirovsky D, Derkach A, Arisa O, Peer CJ, Figg WD, Usmani SZ, Landgren O, Lesokhin AM. Hultcrantz M, et al. Among authors: nemirovsky d. Blood Cancer J. 2024 Sep 19;14(1):164. doi: 10.1038/s41408-024-01136-1. Blood Cancer J. 2024. PMID: 39300066 Free PMC article. No abstract available.
Restarting teclistamab and talquetamab after prolonged dose delay may not require re-step-up dosing.
Tan CR, Wang A, Nemirovsky D, Derkach A, Shekarkhand T, Hamadeh I, Maclachlan K, Hultcrantz M, Hassoun H, Mailankody S, Lesokhin A, Shah UA, Rajeeve S, Hashmi H, Patel D, Firestone R, Jurgens E, Miller K, Shah GL, Scordo M, Landau HJ, Giralt SA, Korde N, Usmani SZ. Tan CR, et al. Among authors: nemirovsky d. Blood Adv. 2025 Jul 8;9(13):3331-3335. doi: 10.1182/bloodadvances.2024015344. Blood Adv. 2025. PMID: 40048741 Free PMC article. No abstract available.
Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma.
Adegbite B, Tan CR, Shekarkhand T, Firestone RS, Jurgens EM, Miller K, Lesokhin AM, Shah GL, Korde N, Rajeeve S, Landau HJ, Scordo M, Hassoun H, Maclachlan KH, Shah UA, Hultcrantz M, Hamadeh IS, Derkach A, Nemirovsky D, Giralt SA, Mailankody S, Usmani SZ, Hashmi H. Adegbite B, et al. Among authors: nemirovsky d. Blood Adv. 2025 Aug 12;9(15):4016-4022. doi: 10.1182/bloodadvances.2025015973. Blood Adv. 2025. PMID: 40315372 Free PMC article.
Barriers to Chimeric Antigen Receptor T-Cell Therapy.
Valtis YK, Chin KK, Nemirovsky D, Devlin SM, Yisraeli Salman M, Boussi L, Cadzin B, McLoughlin C, Cathcart E, Davis P, Brooklyn C, Goldstein T, Famulare C, Shah GL, Walji M, Scordo M, Boardman AP, Shouval R, Stein EM, Geyer MB, Mailankody S, Palomba ML, Usmani SZ, Salles G, Giralt SA, Perales MA, Park JH. Valtis YK, et al. Among authors: nemirovsky d. JAMA Oncol. 2025 Jul 1;11(7):781-784. doi: 10.1001/jamaoncol.2025.1127. JAMA Oncol. 2025. PMID: 40372728
72 results